Difference between revisions of "Focal nodular hyperplasia"

From Libre Pathology
Jump to navigation Jump to search
(split out)
(+infobox)
Line 1: Line 1:
{{ Infobox diagnosis
| Name      = {{PAGENAME}}
| Image      = Focal_nodular_hyperplasia_-_intermed_mag.jpg
| Width      =
| Caption    = Focal nodular hyperplasia. [[H&E stain]].
| Synonyms  =
| Micro      = thick walled blood vessels without bile ducts of same size, bile ductular proliferation at the edge of the fibrosis tissue
| Subtypes  =
| LMDDx      = [[hepatic adenoma]], [[cirrhosis]]
| Stains    =
| IHC        =
| EM        =
| Molecular  =
| IF        =
| Gross      = well circumscribed with capsule, lighter than surrounding parenchyma - may be yellow, +/-stellate central scar with thick vessels
| Grossing  =
| Site      = [[liver]] - see ''[[medical liver disease]]''
| Assdx      =
| Syndromes  = [[hereditary hemorrhagic telangiectasia]]
| Clinicalhx =
| Signs      =
| Symptoms  =
| Prevalence =
| Bloodwork  =
| Rads      = usu. solitary lesion, arterial phase enhancement in triphasic imaging
| Endoscopy  =
| Prognosis  = benign
| Other      =
| ClinDDx    =
| Tx        =
}}
'''Focal nodular hyperplasia''', abbreviated '''FNH''', is a benign [[liver]] lesion, uncommonly seen by pathologists.
'''Focal nodular hyperplasia''', abbreviated '''FNH''', is a benign [[liver]] lesion, uncommonly seen by pathologists.


Line 17: Line 48:
*Lighter than surrounding parenchyma, may be yellow.
*Lighter than surrounding parenchyma, may be yellow.
*+/-Stellate central scar with thick vessels.  
*+/-Stellate central scar with thick vessels.  
**Can be identified on medial imaging.
**Can be identified on medical imaging.


Note: Usually a solitary lesion.<ref name=emedicine_fnh/>
Note: Usually a solitary lesion.<ref name=emedicine_fnh/>

Revision as of 04:45, 17 September 2014

Focal nodular hyperplasia
Diagnosis in short

Focal nodular hyperplasia. H&E stain.

LM thick walled blood vessels without bile ducts of same size, bile ductular proliferation at the edge of the fibrosis tissue
LM DDx hepatic adenoma, cirrhosis
Gross well circumscribed with capsule, lighter than surrounding parenchyma - may be yellow, +/-stellate central scar with thick vessels
Site liver - see medical liver disease

Syndromes hereditary hemorrhagic telangiectasia

Radiology usu. solitary lesion, arterial phase enhancement in triphasic imaging
Prognosis benign

Focal nodular hyperplasia, abbreviated FNH, is a benign liver lesion, uncommonly seen by pathologists.

General

Note:

  • Oral contraceptive pill (OCP) use does not appear to be a factor in the growth of these lesions;[3] however, the study claims there is nothing on hepatocellular adenomas -- yet I found a JAMA paper by Rooks et al.[4] on this topic.

Imaging

  • FNH enhances on the arterial phase in triphasic imaging, i.e. triphasic CT or MRI.[5][1]

Gross

Features:[6]

  • Well circumscribed, but no capsule.
  • Lighter than surrounding parenchyma, may be yellow.
  • +/-Stellate central scar with thick vessels.
    • Can be identified on medical imaging.

Note: Usually a solitary lesion.[5]

Microscopic

Features:[6]

  • Classically a stellate scar that has large arteries with fibromuscular hyperplasia.
    • Thin fibrous septa radiate from the central scar - surrounded by lymphocytes & bile ductules.
      • Normal hepatocytes between fibrous septae.

Practical features:

  1. Thick walled blood vessels.
    • Bile duct of same size not seen.
  2. Bile ductular proliferation at the edge of the fibrosis tissue.
  3. Clinical history: it is a focal lesion.

DDx:

  • Hepatic adenoma - may be difficult to distinguish, if no scar and no ductal proliferation.[7]
  • Cirrhosis - complete nodules
    • FNH has incomplete nodules.

Memory device FNH = focal lesion, numerous bile ductules, hyperplasia of arteries.

Images

www:

See also

References

  1. 1.0 1.1 Brancatelli, G.; Federle, MP.; Grazioli, L.; Blachar, A.; Peterson, MS.; Thaete, L. (Apr 2001). "Focal nodular hyperplasia: CT findings with emphasis on multiphasic helical CT in 78 patients.". Radiology 219 (1): 61-8. PMID 11274535.
  2. Khalid SK, Garcia-Tsao G (August 2008). "Hepatic vascular malformations in hereditary hemorrhagic telangiectasia". Semin. Liver Dis. 28 (3): 247–58. doi:10.1055/s-0028-1085093. PMID 18814078.
  3. Kapp, N.; Curtis, KM. (Oct 2009). "Hormonal contraceptive use among women with liver tumors: a systematic review.". Contraception 80 (4): 387-90. doi:10.1016/j.contraception.2009.01.021. PMID 19751862.
  4. Rooks, JB.; Ory, HW.; Ishak, KG.; Strauss, LT.; Greenspan, JR.; Hill, AP.; Tyler, CW. (Aug 1979). "Epidemiology of hepatocellular adenoma. The role of oral contraceptive use.". JAMA 242 (7): 644-8. PMID 221698.
  5. 5.0 5.1 http://emedicine.medscape.com/article/368377-overview
  6. 6.0 6.1 Cotran, Ramzi S.; Kumar, Vinay; Fausto, Nelson; Nelso Fausto; Robbins, Stanley L.; Abbas, Abul K. (2005). Robbins and Cotran pathologic basis of disease (7th ed.). St. Louis, Mo: Elsevier Saunders. pp. 922. ISBN 0-7216-0187-1.
  7. STC. 19 Jan 2009.